Perceptive Advisors »

Exagen shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Exagen (XGN) shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $345k 115k 3.00

More positions owned by Perceptive Advisors

Praxis Precision Medicines I Com New (PRAX)
Celcuity (CELC)
Ascendis Pharma A/s Sponsored Adr (ASND)
Roivant Sciences SHS (ROIV)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Rhythm Pharmaceuticals (RYTM)
Spyre Therapeutics Com New (SYRE)
Nuvalent Inc-a (NUVL)
Edgewise Therapeutics (EWTX)
Protagonist Therapeutics (PTGX)
Apogee Therapeutics (APGE)
Travere Therapeutics (TVTX)
Amylyx Pharmaceuticals (AMLX)
Immatics SHS (IMTX)
Relay Therapeutics (RLAY)

View all positions for Perceptive Advisors

Top funds holding Exagen

Balyasny Asset Management
Wexford Capital
Rtw Investments
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Silvercrest Asset Management Group
Kennedy Capital Management
FourWorld Capital Management
Mink Brook Asset Management
Susquehanna International
Squarepoint Ops
GSA Capital Partners
Nano Cap New Millennium Growth Fund
Sei Investments

View all funds holding Exagen